60 Degrees Pharmaceuticals (SXTP) Inventory (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Inventory of $910603.0 for Q1 2026, up 17.76% year-over-year from $773238.0 in Q1 2025, and little changed quarter-over-quarter from $908601.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Inventory (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Inventory for 5 consecutive years, with $910603.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 17.76% year-over-year to $910603.0; the TTM figure through Mar 2026 stood at $910603.0 (up 17.76% YoY), while the FY2025 annual figure was $908601.0, up 105.21% from the prior year.
- Inventory held at $910603.0 in Q1 2026 per SXTP's latest filing, from $908601.0 in the prior quarter.
- Across five years, Inventory topped out at $910603.0 in Q1 2026 and bottomed at $426020.0 in Q2 2024.
- Historically, Inventory has averaged $627668.0 across 5 years, with a median of $598319.0 in 2023.
- Annual changes were most pronounced in 2024 — Inventory slumped 42.52% — and 2025, when it surged 105.21%.
- 60 Degrees Pharmaceuticals' Inventory stood at $678916.0 in 2022, then tumbled by 31.34% to $466169.0 in 2023, then declined by 5.02% to $442764.0 in 2024, then jumped by 105.21% to $908601.0 in 2025, then grew by 0.22% to $910603.0 in 2026.
- Business Quant data shows SXTP's Inventory at $910603.0 in Q1 2026, $908601.0 in Q4 2025, and $527004.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 877,945.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 910,603.00 |
| Dec 31, 2025 | 908,601.00 |
| Sep 30, 2025 | 527,004.00 |
| Jun 30, 2025 | 799,421.00 |
| Mar 31, 2025 | 773,238.00 |
| Dec 31, 2024 | 442,764.00 |
| Sep 30, 2024 | 452,036.00 |
| Jun 30, 2024 | 426,020.00 |
| Mar 31, 2024 | 435,377.00 |
| Dec 31, 2023 | 466,169.00 |
| Sep 30, 2023 | 598,319.00 |
| Jun 30, 2023 | 741,216.00 |
| Dec 31, 2022 | 678,916.00 |